Health X PlatformQ3 FY24

Health X Platform Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹273.2Market Cap: ₹869 CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

No

0 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • RetailerShakti is identified as the clear growth engine for SastaSundar, expected to deliver substantial growth going forward.
  • The company is targeting around 15,000 actively transacting retailers by the end of the fiscal year, up from about 11,100 currently.
  • Retailer additions are ongoing, including expansion into newer geographies like the northeast, with approximately 1,000 retailers being added quarterly.
  • Growth derives both from acquiring new retailers and increasing wallet share of existing retailers.
  • Healthbuddy growth has slowed and is expected to remain flat or modest; management focus has shifted towards RetailerShakti.
  • Industry discounting has normalized, leading to sustainable but slower e-pharmacy growth (20%-30% year-on-year).
  • Revenue for RetailerShakti grew ~20% quarter-on-quarter recently, with operational profitability expected soon.
  • No formal revenue guidance is provided, but management is confident in the growth prospects of the RetailerShakti platform.

See what Health X Platform management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no explicit mention of any current or immediate plans for fundraising through debt or equity in the Q3 FY24 earnings call.
  • The management emphasized focusing on cost-cutting, operational improvements, and achieving positive EBITDA next year.
  • Cash utilization plans are contingent upon completing the simplification of the corporate structure, which is currently delaying liquidity deployment.
  • Cash is largely held in a subsidiary, making direct utilization tax-inefficient until simplification is done.
  • No direct reference to new debt or equity fundraising was made; management is prioritizing sustainability and organic growth via RetailerShakti.
  • The company expects to work on structural simplification before any cash deployment or external financing decisions are made.

See what Health X Platform management said on order book — free account, 30 seconds.

Capex plans

No
  • No significant warehouse expansion plans in the next 1-2 quarters; current seven warehouses sufficient for planned growth (Page 14).
  • Capex requirements are minimal, with a focus on cost efficiency and stability (Page 15).
  • No plans to start offline presence despite having no agreement restricting it; focus remains on RetailerShakti digital model (Page 15).
  • Investment and growth focus predominantly on RetailerShakti platform and technology enhancement (Page 4, 5).
  • Exploring product credit offerings to retailers in collaboration with FinTechs, NBFCs, and banks, which may be a future strategic investment area (Page 14).
  • No detailed guidance given on revenue or profitability projections or specific capital expenditure for future quarters (Page 14).

Track Health X Platform — get its next earnings analysis in your feed

How does Health X Platform rank vs peers in Healthcare Services?

Pro feature
ThisHealth X Platform
Rev 3Mar 2

How does Health X Platform rank in Healthcare Services?

Compare Health X Platform against every Healthcare Services company (Q3 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →